Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × exemestane × Clear all

Sponsor

Conditions

Breast Neoplasms 67 Neoplasm Metastasis 6 Breast Neoplasms, Male 3 Neoplasms 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Skin Diseases 1 Post Menopausal Women With Early Breast Cancer 1 Pain 1 Obesity 1 Metastatic Beast Cancer 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Invasive Early Breast Cancer 1 Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1 Fatigue 1 Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Advanced Breast Carcinoma 1 Advanced Breast Cancer 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡